Opioid Rotation From Opana ER Following FDA Call for Removal
Loading...
Issue Date
2017-08-16
Authors
Cleary, Jacqueline H.
Brennan, Michael J.*
Fudin, Jeffrey
Degree
Advisor
Committee Members
Journal Title
Journal ISSN
Volume Title
Abstract
Switching from one opioid to another is never easy, but when the FDA pulls a product from the market, the urgency to find a replacement may make the process that much more difficult. A review of what products may be an appropriate substitute for Opana ER and why is provided.
Citation
Cleary, Jacqueline, et al. “Opioid Rotation From Opana ER Following FDA Call for Removal.” Practical Pain Management, vol. 17, no. 6, 2017, https://www.practicalpainmanagement.com/treatments/pharmacological/opioids/opioid-rotation-opana-er-following-fda-call-removal.
ACPHS Research Commons URI
Description
Click on the Resource Link to access the article (may not be free).